Methocarbamol + Pyridostigmine Bromide Interaction
Majorinteraction on record
Description
Methocarbamol may inhibit the effect of pyridostigmine bromide. Patients with myasthenia gravis should be monitored closely for weakness symptoms; treatment should be stopped if observed.
Mechanism
Inhibition of pyridostigmine bromide effect
Source: NLP:methocarbamol